Exclusive

Publication

Byline

Clinical Trial: Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer

U.S., Nov. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07224022) titled 'Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer' on Oct. 30. Brief Sum... Read More


ANALYSIS: Can Peter Obi cause a swing in 2025 Anambra governorship election?

Nigeria, Nov. 4 -- The 2025 Anambra governorship election is likely to be a test of Peter Obi's political strength. The former governor of the state and 2023 Labour Party (LP) presidential candidate ... Read More


Glenmark Pharmas US subsidiary to launch 8.4% sodium bicarbonate injection in US market

Mumbai, Nov. 4 -- The product has been deemed bioequivalent and therapeutically equivalent to the reference listed drug, 8.4% Sodium Bicarbonate Injection, 50 mEq/50 mL (1 mEq/mL) of Abbott Laboratori... Read More


Indonesia pushes local alternatives for thrift traders amid import ban

Jakarta, Nov. 4 -- President Prabowo Subianto has directed the Ministry of Micro, Small, and Medium Enterprises (MSMEs) to develop alternative products for thrift businesses, following the government'... Read More


IT Dept raids Utkal Builders in Bhubaneswar over large-scale tax evasion allegations

Bhubaneswar, Nov. 4 -- The Income Tax (IT) Department on Tuesday conducted extensive raids on multiple premises linked to Utkal Builders, one of the most prominent real estate firms in Bhubaneswar, in... Read More


Stock market off to a quiet start! Pharma stocks race ahead while auto sector stalls

Mumbai/IBNS, Nov. 4 -- The Indian stock market opened flat on Tuesday with BSE Sensex opening 0.69 points higher and NSE Nifty50 moving 14 points upward, media reports said. The BSE Sensex opened at ... Read More


Titan Company rises after strong Q2 results

Mumbai, Nov. 4 -- The company's consolidated revenue jumped 28.5% year-on-year to Rs 18,837 crore in Q2 FY26 from Rs 14,656 crore in Q2 FY25, driven by festive-led jewellery demand, robust internation... Read More


Nuapada bypoll: Jay Dholakia hits back at Naveen Patnaik, accuses BJD chief of opportunism

Bhubaneswar, Nov. 4 -- A day after Biju Janata Dal (BJD) president and Leader of Opposition Naveen Patnaik launched a scathing attack on the Bharatiya Janata Party (BJP) during his campaign in Nuapada... Read More


Economic Buzz: Australia central bank keeps key rate steady

Mumbai, Nov. 4 -- The Reserve Bank of Australia maintained its key interest rate, as widely expected, on Tuesday. The policy board governed by Michele Bullock voted to hold the cash rate at 3.60 perc... Read More


In any trade agreement, you lose some, you win some, but do you compromise sovereignty? - Hafiz Hassan

Kuala Lampur, Nov. 4 -- Yesterday, I wrote of back-end clauses in an agreement, which go by different names - conflict clauses, savings clauses, compatibility clauses. Such clauses are in the recipro... Read More